Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
52.7M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
1.02K
-
Shares change
-
-16.8K
-
Total reported value, excl. options
-
$9.01K
-
Value change
-
-$21K
-
Number of buys
-
3
-
Number of sells
-
-3
-
Price
-
$9.01
Significant Holders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) as of Q1 2019
8 filings reported holding MBOT - Microbot Medical Inc. - Common stock, par value $0.01 per share as of Q1 2019.
Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.02K shares
of 52.7M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include ROYAL BANK OF CANADA (620 shares), WELLS FARGO & COMPANY/MN (201 shares), FMR LLC (200 shares), Federation des caisses Desjardins du Quebec (4 shares), BREWIN DOLPHIN Ltd (1 shares), CITIGROUP INC (0 shares), CITADEL ADVISORS LLC (0 shares), BANK OF AMERICA CORP /DE/ (0 shares), RENAISSANCE TECHNOLOGIES LLC (196K shares), and BlackRock Inc. (174K shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.